Every prescription that enters a community pharmacy passes through a systematic verification process before a single tablet is counted. This is the pharmacist's clinical and legal check — the safety net between prescriber and patient. It is not a formality. It is the reason pharmacists exist within the medicines supply chain.

For patients, the process is invisible — a brief wait while "the pharmacist checks your prescription". For the pharmacist, it involves a structured sequence of legal, clinical, and practical assessments.

Step 1: Legal validity

Before considering the clinical content, the pharmacist must confirm that the prescription is legally valid. The requirements differ by prescription type:

NHS prescriptions (FP10 and electronic EPS)

Private prescriptions

Private prescriptions carry similar requirements but are not standardised to the FP10 format. The prescriber must be identifiable, the prescription must be signed, and the medicine details must be unambiguous. For controlled drugs (Schedule 2 and 3), additional requirements apply — see the controlled drugs dispensing guide.

Common legal issues

• Missing signature: the prescription cannot be dispensed without the prescriber's signature
• Ambiguous quantity: "supply one month" is not legally precise for controlled drugs — the exact number of dosage units must be specified
• Expired prescription: NHS prescriptions older than six months, and CD prescriptions older than 28 days, are not legally dispensable
• Prescriber not registered: the pharmacist must be satisfied that the prescriber is registered with the appropriate professional body (GMC, GPhC, NMC, or HCPC for non-medical prescribers)

Step 2: Clinical screening

Once legality is confirmed, the pharmacist performs a clinical check. This is where pharmaceutical expertise directly protects the patient.

Dose appropriateness

Is the prescribed dose within the normal therapeutic range for the drug, the indication, and the patient's age and weight? The pharmacist checks against the BNF (British National Formulary) or BNF for Children, looking for:

• Doses above the recommended maximum
• Doses below the therapeutic minimum (which may indicate a prescribing error rather than a deliberate sub-therapeutic dose)
• Weight-based dosing for paediatric prescriptions — is the dose appropriate for the child's age?
• Renal or hepatic dose adjustment — if the patient has known impairment, has the dose been adjusted?

Drug interactions

The pharmacist checks the prescribed medicine against the patient's medication record (PMR) for clinically significant interactions. Modern PMR systems flag interactions automatically, but the pharmacist must exercise clinical judgement about which flags represent genuine risk versus theoretical or manageable interactions.

High-risk interaction categories include:

Allergies and contraindications

The PMR should record known allergies. The pharmacist checks whether the prescribed medicine — or any of its excipients — is contraindicated for the patient. Common flags include penicillin allergy (relevant for amoxicillin, co-amoxiclav, flucloxacillin), sulfa allergy, and lactose intolerance (relevant for some tablet formulations).

Therapeutic duplication

Is the patient already taking a medicine from the same therapeutic class? Prescribers sometimes inadvertently add a new medicine without stopping the existing one — particularly after hospital discharge, where the hospital discharge letter and the GP's repeat prescribing system may not be synchronised.

Appropriateness for the patient

The pharmacist considers whether the medicine is suitable for this specific patient:

• Is the formulation appropriate? (A patient with swallowing difficulties should not receive large tablets without discussion)
• Is the device usable? (An inhaler prescribed without checking the patient can operate it)
• Is the medicine compatible with pregnancy or breastfeeding, if relevant?
• Are there safeguarding concerns? (Large quantities of paracetamol, unusual patterns of controlled drug prescribing)

Step 3: Practical considerations

Beyond legality and clinical safety, the pharmacist considers practical factors:

• Stock availability: is the medicine in stock, or does it need to be ordered? If ordering, what is the expected delivery time and does the patient need an interim supply?
• Generic substitution: NHS prescriptions are generally written generically. The pharmacist selects a suitable manufacturer's product. Where brands are clinically significant (e.g. modified-release preparations, epilepsy medicines, some inhalers), the pharmacist ensures the correct brand is supplied.
• Patient counselling needs: new medicines, dose changes, and high-risk medicines require patient counselling at the point of supply. The pharmacist identifies which prescriptions need a conversation and plans accordingly.

Step 4: Accuracy check

After the medicine has been assembled (labelled, counted, and bagged), the pharmacist — or an accuracy-checking pharmacy technician (ACPT) — performs a final accuracy check:

• Correct medicine (right drug, right strength, right form)
• Correct quantity
• Correct label (patient name, dose instructions, warnings)
• Correct patient

This is the last check before the medicine leaves the pharmacy. It catches assembling errors (wrong strength picked from the shelf, wrong quantity counted, wrong label applied) that the clinical check could not have detected because the clinical check occurs before the physical dispensing process.

The scale of the task

Across England's approximately 13,147 registered community pharmacies, according to PharmSee's register data, pharmacists collectively process hundreds of millions of prescription items per year. NHSBSA dispensing data shows that the average community pharmacy dispenses several thousand items per month. Each one passes through the verification process described above.

The speed at which pharmacists perform these checks can obscure their complexity. A pharmacist handling 200 items per day is making hundreds of clinical and legal judgements, each one a potential intervention point where a prescribing error, an interaction, or a safety concern can be caught before it reaches the patient.

Where to learn more

• Explore pharmacy roles and career paths on PharmSee Jobs
• Compare pharmacist salary data across different practice settings
• Find pharmacies near you on the pharmacy finder

Sources: Human Medicines Regulations 2012 (legislation.gov.uk); British National Formulary (bnf.nice.org.uk); GPhC Standards for Pharmacy Professionals; PharmSee pharmacy register data (13,147 pharmacies as of April 2026).